FDA Accepts Supplement Application for IC-GREEN by RENEW PHARMS
The FDA has accepted a supplemental application for IC-GREEN, an imaging agent containing Indocyanine Green, submitted by RENEW PHARMS.
Company
Pharmaceutical intelligence for IC-GREEN with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.